Bruker BRKR
NASDAQ BRKR
$63.06 +2.39 (+3.94%)
As of: Sep 17, 2026 · 3:59 PM EDT

Bruker (BRKR) Cash from Investing Activities (2010 - 2026)

Bruker's (BRKR) quarterly Cash from Investing Activities came in at -$25.3 million in Q2 2026, up 72.23% on a YoY basis from -$14.7 million in Q2 2025, and up 36.27% quarter-over-quarter from -$39.7 million in Q1 2026.

Analysis

Bruker (BRKR) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Bruker (BRKR) has reported Cash from Investing Activities for 17 consecutive years, with -$25.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Investing Activities rose 72.23% year-over-year to -$25.3 million; the trailing twelve-month figure through Jun 2026 stood at -$144.3 million (up 41.2% YoY), and the FY2025 full-year result was -$196.5 million, up 88.82% from the prior year.
  • Cash from Investing Activities climbed to -$25.3 million in Q2 2026 per BRKR's latest filing, from -$39.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $57.1 million in Q2 2022 and bottomed at -$1.3 billion in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$144.2 million across 5 years, with a median of -$59.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities soared 179.97% in 2022, then sank 4995.77% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$149.3 million in 2022, then soared by 75.35% to -$36.8 million in 2023, then sank by 64.67% to -$60.6 million in 2024, then increased by 8.42% to -$55.5 million in 2025, then surged by 54.41% to -$25.3 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$25.3 million, -$39.7 million, and -$55.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 164.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -10.15 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -1.03 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -122.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -3.51 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -7.06 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -66.70 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -2.09 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -7.74 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -25.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.30 Mn
Mar 31, 2026 -39.70 Mn
Dec 31, 2025 -55.50 Mn
Sep 30, 2025 -23.80 Mn
Jun 30, 2025 -91.10 Mn
Mar 31, 2025 -26.10 Mn
Dec 31, 2024 -60.60 Mn
Sep 30, 2024 -67.60 Mn
Jun 30, 2024 -1.32 Bn
Mar 31, 2024 -304.20 Mn
Dec 31, 2023 -36.80 Mn
Sep 30, 2023 -155.00 Mn
Jun 30, 2023 -26.00 Mn
Mar 31, 2023 -108.20 Mn
Dec 31, 2022 -149.30 Mn
Sep 30, 2022 -57.60 Mn
Jun 30, 2022 57.10 Mn
Mar 31, 2022 -101.80 Mn
Dec 31, 2021 -48.60 Mn
Sep 30, 2021 -48.40 Mn